JPRN-UMIN000004884已完成2 期
A phase II study of Oxaliplatin Reintroduction in patients pretreated with Oxaliplatin and Irinotecan for Advanced Colorectal Cancer - A phase II study of Oxaliplatin Reintroduction in patients pretreated with Oxaliplatin and Irinotecan (RE-OPEN study)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Severe peripheral neuropathy. 2.History of the serious hypersensitivity for drugs. 3.Active infection. 4.Complications (Evidence of interstinal lung disease, emphysema, pulmonary fibrosis, paralytic or mechanical bowel obstruction, uncontrolled hypertension, uncontrolled diabetes mellitus, cirrhosis, active cardiovascular disease, or past or current history (within 3 months) of myocardial infarction, uncontrolled angina pectoris or arrythmia. 5.Multiple primary cancer within 5years. 6.Need to drain pleural effusion, ascites or pericardial effusion. 7.Uncontrolled diarrhea. 8.Radiological evidence of brain cancer. 9.Clinically significant mental or psychological disease. 10.Other conditions not suitable for this study.
研究者
相似试验
招募中
2 期
Phase II Study of Weekly Oxaliplatin With Continous Infusion Fluorouracil And Concurrent Radiation for Treatment of Localised Oesophageal CarcinomaHistologically confirmed localised squamous cell carcinoma of the oesophagusAdenocarcinoma of the oesophagusCancer - Oesophageal (gullet)ACTRN12605000106639Princess Alexandra Hospital30
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
已完成
3 期
A randomized phase III study of oxaliplatin based chemotherapy versus combination chemotherapy of TS-1,irinotecan and bevacizumab as first line therapy for unresectable or recurrent colorectal cancerJPRN-UMIN000007834The Tokyo Cooperative Oncology Group450
进行中（未招募）
不适用
A randomized phase II study of oxaliplatin and capecitabine combination vs irinotecan and capecitabine combination for the treatment of elderly patients with advanced colorectal cancer.EUCTR2004-001159-12-ITAZIENDA OSPEDALIERA S. CARLO
已完成
不适用
Safety of the oxaliplatin readministration by the desensitization for metastatic colorectal cancer patients having oxaliplatin allergyColorectal carcinomaJPRN-UMIN000010128Aichi Cancer Center Hospital10